Aim Immunotech Inc. · AMEX:AIM
Aim Immunotech — Proxy Contest (November 2024)
5 slides from Aim Immunotech's proxy contest presentation, Nov 25, 2024
Slide 1: Our Nominees
Salm HowTo | Contact Vote Us AIM our Important ImmunoTech | Nominees | Materials Our Nominees The Board has the right mix of experience and skillsets to oversee the Company's strategy for value creation. Stewart L. Appelrouth Mr. Appelrouth has valuable financial and regulatory expertise as a certif
Slide 2: Thomas K. Equels, M.S., J.D.
Thomas K. Equels, M.S., J.D. Mr. Equels is Executive Vice Chairman, Chief Executive Officer and President and has over 25 years of experience as a practicing attorney specializing in complex business litigation. He also has extensive experience in clinical trial design and development, creating inte
Slide 3: Nancy K. Bryan
Nancy K. Bryan Key Qualifications Life Science Industry Experience CEO Experience Marketing and Commercialization Experience Ms. Bryan possesses deep commercial, marketing, business development and corporate finance expertise from her service at major pharmaceutical companies including Merck, GlaxoS
Slide 4: AIM ImmunoTech Issues Presentation Detailing Case for Re-Electing Current Directors
@ AIM ImmunoTech @ AIM ImmunoTech Issues Presentation Detailing Case for Re-Electing Current Directors to Oversee Continued Momentum and Drive Strategy to Create Long-Term Value for Patients and Shareholders
Slide 5: AIM ImmunoTech social media post on director re-election presentation
nN AIM ImmunoTech QRAIM 1,342 followers th: ® AIM ImmunoTech Issues Presentation Detailing Case for Re-Electing Current Directors to Oversee Continued Momentum and Drive Strategy to Create Long-Term Value for Patients and Shareholders https://bit.ly/40Ycbnd #PancreaticCancer #OvarianCancer #BreastCa
AIM ImmunoTech — Proxy Contest (November 2024) on 6ix